Literature DB >> 22750443

Comparative analysis of the substrate preferences of two post-proline cleaving endopeptidases, prolyl oligopeptidase and fibroblast activation protein α.

Kalyani Jambunathan1, Douglas S Watson, Aaron N Endsley, Krishna Kodukula, Amit K Galande.   

Abstract

Post-proline cleaving peptidases are promising therapeutic targets for neurodegenerative diseases, psychiatric conditions, metabolic disorders, and many cancers. Prolyl oligopeptidase (POP; E.C. 3.4.21.26) and fibroblast activation protein α (FAP; E.C. 3.4.24.B28) are two post-proline cleaving endopeptidases with very similar substrate specificities. Both enzymes are implicated in numerous human diseases, but their study is impeded by the lack of specific substrate probes. We interrogated a combinatorial library of proteolytic substrates and identified novel and selective substrates of POP and FAP. These new sequences will be useful as probes for fundamental biochemical study, scaffolds for inhibitor design, and triggers for controlled drug delivery.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22750443      PMCID: PMC3500622          DOI: 10.1016/j.febslet.2012.06.015

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  25 in total

Review 1.  On the role of prolyl oligopeptidase in health and disease.

Authors:  J A García-Horsman; P T Männistö; J I Venäläinen
Journal:  Neuropeptides       Date:  2006-12-29       Impact factor: 3.286

2.  New fluorogenic substrates for the study of secondary specificity of prolyl oligopeptidase.

Authors:  C Noula; G Kokotos; T Barth; C Tzougraki
Journal:  J Pept Res       Date:  1997-01

3.  Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein.

Authors:  Kyung N Lee; Kenneth W Jackson; Victoria J Christiansen; Chung S Lee; Jin-Geun Chun; Patrick A McKee
Journal:  Blood       Date:  2005-10-13       Impact factor: 22.113

4.  The specificity of prolyl endopeptidase from Flavobacterium meningoseptum: mapping the S' subsites by positional scanning via acyl transfer.

Authors:  F Bordusa; H D Jakubke
Journal:  Bioorg Med Chem       Date:  1998-10       Impact factor: 3.641

5.  Peptide substrate profiling defines fibroblast activation protein as an endopeptidase of strict Gly(2)-Pro(1)-cleaving specificity.

Authors:  Conrad Yap Edosada; Clifford Quan; Thuy Tran; Victoria Pham; Christian Wiesmann; Wayne Fairbrother; Beni B Wolf
Journal:  FEBS Lett       Date:  2006-02-03       Impact factor: 4.124

6.  Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites.

Authors:  Saurabh Aggarwal; W Nathaniel Brennen; Thomas P Kole; Elizabeth Schneider; Ozlem Topaloglu; Melinda Yates; Robert J Cotter; Samuel R Denmeade
Journal:  Biochemistry       Date:  2007-12-21       Impact factor: 3.162

Review 7.  On the edge of validation--cancer protease fibroblast activation protein.

Authors:  Beni B Wolf; Clifford Quan; Thuy Tran; Christian Wiesmann; Daniel Sutherlin
Journal:  Mini Rev Med Chem       Date:  2008-06       Impact factor: 3.862

8.  Fluorescence resonance energy transfer (FRET) peptides and cycloretro-inverso peptides derived from bradykinin as substrates and inhibitors of prolyl oligopeptidase.

Authors:  Silvia S Gorrão; Jefferson P Hemerly; Aurelio R Lima; Robson L Melo; Zoltán Szeltner; László Polgár; Maria A Juliano; Luiz Juliano
Journal:  Peptides       Date:  2007-08-23       Impact factor: 3.750

9.  A broad-spectrum fluorescence-based peptide library for the rapid identification of protease substrates.

Authors:  Daniel A Thomas; Peter Francis; Carla Smith; Steven Ratcliffe; Nicholas J Ede; Corinne Kay; Gareth Wayne; Steve L Martin; Keith Moore; Augustin Amour; Nigel M Hooper
Journal:  Proteomics       Date:  2006-04       Impact factor: 3.984

10.  A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation.

Authors:  Amit Gaggar; Patricia L Jackson; Brett D Noerager; Philip J O'Reilly; D Brent McQuaid; Steven M Rowe; J P Clancy; J Edwin Blalock
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

View more
  5 in total

1.  Fibroblast activation protein α activatable theranostic pro-photosensitizer for accurate tumor imaging and highly-specific photodynamic therapy.

Authors:  Yong Luo; Zishan Zeng; Ting Shan; Xiaoyu Xu; Jie Chen; Yuanfeng He; Tao Zhang; Zeqian Huang; Guihong Chai; Yanjuan Huang; Yanfang Zhao; Chunshun Zhao
Journal:  Theranostics       Date:  2022-05-01       Impact factor: 11.600

Review 2.  Post-Proline Cleaving Enzymes (PPCEs): Classification, Structure, Molecular Properties, and Applications.

Authors:  Anis Baharin; Tiew-Yik Ting; Hoe-Han Goh
Journal:  Plants (Basel)       Date:  2022-05-18

3.  Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations.

Authors:  M M Koczorowska; S Tholen; F Bucher; L Lutz; J N Kizhakkedathu; O De Wever; U F Wellner; M L Biniossek; A Stahl; S Lassmann; O Schilling
Journal:  Mol Oncol       Date:  2015-08-11       Impact factor: 6.603

4.  Human FGF-21 Is a Substrate of Fibroblast Activation Protein.

Authors:  Andrew L Coppage; Kathryn R Heard; Matthew T DiMare; Yuxin Liu; Wengen Wu; Jack H Lai; William W Bachovchin
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

5.  Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs.

Authors:  Fiona M Keane; Tsun-Wen Yao; Stefanie Seelk; Margaret G Gall; Sumaiya Chowdhury; Sarah E Poplawski; Jack H Lai; Youhua Li; Wengen Wu; Penny Farrell; Ana Julia Vieira de Ribeiro; Brenna Osborne; Denise M T Yu; Devanshi Seth; Khairunnessa Rahman; Paul Haber; A Kemal Topaloglu; Chuanmin Wang; Sally Thomson; Annemarie Hennessy; John Prins; Stephen M Twigg; Susan V McLennan; Geoffrey W McCaughan; William W Bachovchin; Mark D Gorrell
Journal:  FEBS Open Bio       Date:  2013-12-08       Impact factor: 2.693

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.